Searched for
MANUFACTURING COSTS INDIA
Pharma stocks slide as Trump's 100% generic drug tariff plan spooks investorsIndian drug shares declined Wednesday following US President Trump's tariff announcement. These proposed tariffs will significantly impact ...
Solar cell makers flag investor jitters over sourcing rule reliefIndia extended a solar cell sourcing exemption for certain projects by seven months. Local manufacturers express concerns about this decisi...
Tariff hike by US will only increase drug prices: Dr Reddy's CEOUS tariff increases on generic medicines will lead to higher drug prices in India. Dr Reddy's Laboratories CEO Erez Israeli stated relocati...
India must cut launch costs, boost local manufacturing to become world's third-largest space economy: DoT officialIndia is on a mission to become the world's third-largest space economy by the year 2033. This ambitious vision hinges on vital changes in ...
Generic drugmaker Sandoz to engage with US after Trump tariff threatUS President Donald Trump threatened steep tariffs on generic drugmakers. He stated medicines must be manufactured locally or face signific...
Explained: What Donald Trump's up to 200% pharma tariffs mean for Indian investorsDonald Trump's announcement of tariffs of up to 200% on pharmaceutical imports triggered a selloff in Indian pharma stocks. However, analys...
Indian pharma firms may yet survive Trump's 200% tariff bombshellDonald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say...
200% Trump tariff shock? India’s cheap pills may still beat US rivalsUS President Donald Trump's proposed tariffs of up to 200% on imported generic medicines could put pressure on India's pharmaceutical expor...
Trump’s 100% generic drug duty threatens US low-cost supplyPresident Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028...
Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% stormTrump's generic drug tariffs plan provides Indian drugmakers a two-year duty-free window. This allows companies time to reassess manufactur...
Trump's 200% drug tariff plan: Is India's pharma industry about to face an economic storm?The United States is set to implement a phased approach to tariffs on generic drug imports, beginning at zero percent and escalating to one...
Maruti Suzuki to hike car prices by up to Rs 30,000 from AugustMaruti Suzuki will increase prices across its entire model range. This price adjustment will take effect starting in August 2026. The compa...
Maruti Suzuki announces price hike of up to Rs 30,000 across models, carmaker cites input cost pressureMaruti Suzuki will increase vehicle prices by up to thirty thousand rupees starting August 2026. This decision follows sustained increases ...
Dixon Tech shares down 30% from 52-week high. Can these 3 triggers reignite the rally for 79 lakh shareholdersDixon Technologies shares may see a rally after recent declines from their peak. Government approval for the Vivo joint venture is a signif...
Seoul Semicon’s India plans; Specialty healthcare attracts VCsSouth Korea's Seoul Semiconductor is planning a manufacturing foray in India. This and more in today's ETtech Top 5.
India textile exports face execution test despite China+1 tailwindsIndia's textile sector is well placed to benefit from China+1 sourcing and new trade agreements, but long-term export gains will hinge on i...
Downstream aluminium industry says duty structure hurting competitiveness, seeks reliefDownstream aluminium manufacturers are urging the government to reduce import duties. Higher global metal prices and freight costs pressure...